首页|硝苯地平与硫酸镁在妊娠期高血压疾病治疗中的联合应用效果及安全性评价

硝苯地平与硫酸镁在妊娠期高血压疾病治疗中的联合应用效果及安全性评价

扫码查看
目的 评价在妊娠期高血压疾病治疗中的联合应用硝苯地平缓释片与硫酸镁注射液的效果及安全性.方法 回顾性选取2021年10月—2024年4月山东省德州市齐河县人民医院收治的100例妊娠期高血压综合征患者的临床资料,根据患者接受的不同治疗方式,分为单一组(50例,仅采用硝苯地平治疗)和联合组(50例,采用硫酸镁联合硝苯地平治疗).对两组患者血压指标、血液流变学指标、治疗效果以及不良反应发生情况进行对比.结果 治疗后,联合组的血压水平低于单一组,血压达标时间短于单一组,差异有统计学意义(P均<0.05).联合组血液流变学指标优于单一组,差异有统计学意义(P<0.05).联合组的治疗总有效率为96.00%(48/50),高于单一组的80.00%(40/50),差异有统计学意义(χ2=6.061,P<0.05).两组患者治疗后不良反应总发生率对比,差异无统计学意义(P>0.05).结论 硝苯地平缓释片与硫酸镁注射液的联合应用在妊娠期高血压疾病治疗中显示出更优的疗效,能够更有效地降低血压,改善血液流变学指标,且安全性良好.
Combined Application Effect and Safety Evaluation of Nifedipine and Magnesium Sulfate in the Treatment of Hypertensive Disorder Complicat-ing Pregnancy
Objective To evaluate the efficacy and safety of nifedipine combined with magnesium sulfate in the treat-ment of hypertensive disorder complicating pregnancy.Methods The clinical data of 100 patients with pregnancy-induced hypertension syndrome admitted to Qihe County People's Hospital from October 2021 to April 2024 were ret-rospectively selected.According to the different treatment methods received by the patients,they were divided into single group(50 cases,only treated with nifedipine)and combined group(50 cases,treated with magnesium sulfate combined with nifedipine).The blood pressure index,hemorheology index,treatment effect and adverse reactions of patients in two groups were compared.Results After treatment,the blood pressure level of the combined group was lower than that of the single group,and the time of blood pressure reaching the standard was shorter than that of the single group,the differences were statistically significant(both P<0.05).The hemorheological indexes of the combined group were better than those of the single group,and the difference was statistically significant(P<0.05).The total ef-fective rate of treatment in the combined group was 96.00%(48/50),which was higher than 80.00%(40/50)in the single group,and the difference was statistically significant(χ2=6.061,P<0.05).There was no significant difference in the total incidence of adverse reactions between patients in two groups after treatment(P>0.05).Conclusion The com-bined application of nifedipine and magnesium sulfate shows better curative effect in the treatment of hypertensive dis-order complicating pregnancy,which can more effectively reduce blood pressure,improve hemorheology indexes,and has good safety.

NifedipineMagnesium sulfateHypertension in pregnancyCombined treatmentSafety assessment

刘亚楠、程青、孙丽丽

展开 >

山东省德州市齐河县人民医院产科,山东 德州 251100

硝苯地平 硫酸镁 妊娠期高血压 联合治疗 安全性评估

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(24)